Napo Pharmaceuticals : triple bottom line of people, planet, and profits (A) / Kristiana Raube.

Format:

Book

Author/Creator:

Raube, Kristiana, author.

Series:

SAGE Knowledge. Cases.

SAGE Knowledge. Cases

Language:

English

Subjects (All):

Napo Pharmaceuticals.

Pharmaceutical biotechnology industry--Case studies.

Pharmaceutical biotechnology industry.

Social responsibility of business--Case studies.

Social responsibility of business.

Business planning--Case studies.

Business planning.

Genre:

Case studies.

Physical Description:

1 online resource.

Place of Publication:

London : SAGE Publications Ltd, 2017.

System Details:

text file

Summary:

The Napo Pharmaceuticals case study provides students with an example of a biotech company that has pursued a triple bottom line of people, planet, and profit while making life-saving drugs like crofelemer to deal with diarrhea in adult HIV/AIDS patients and potentially diarrhea for children and other neglected diseases around the world. The case study focuses on CEO and founder, Lisa Contes challenging road to the point where she and her distribution partners achieved FDA approval for the drug. The case study outlines the issues such mission-oriented biotech companies faced in the more typical profit-oriented world of biotech.

Notes:

Originally published in Raube, K. (2014). Napo Pharmaceuticals: Triple Bottom Line of People, Planet, and Profits (A). The Berkeley-Haas Case Series. University of California, Berkeley. Haas School of Business.

No ILL or scholarly sharing allowed.

Description based on XML content.

ISBN:

9781526408730

OCLC:

1017724194

Access Restriction:

Restricted for use by site license.